Effect of Intermittent Fasting on Weight Loss and Risk Factors for Cardiovascular Disease and Diabetes: A Systematic Review by Antonelli, Ray
  
 
  
 
 
 
Effect of Intermittent Fasting on Weight Loss and Risk Factors for 
Cardiovascular Disease and Diabetes: A Systematic Review 
 
 
By 
 
Ray Antonelli 
 
 
 
A Master’s Paper submitted to the faculty of 
the University of North Carolina at Chapel Hill 
in partial fulfillment of the requirements for  
the degree of Master of Public Health in 
the Public Health Leadership Program 
 
 
 
Chapel Hill 
 
Summer II 2017 
 
 
 
 
     
   
     
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 2 
 
ABSTRACT 
 
BACKGROUND: Obesity is a global pandemic associated with substantial morbidity, mortality, 
and economic costs, yet there are few effective clinical interventions for weight loss.   One novel 
approach is intermittent fasting, a dietary pattern in which patients are allocated to a 
predetermined number of fasting days per week and are permitted to consume food ad libitum on 
non-fasting days.  
 
OBJECTIVES: To conduct a systematic review of the efficacy of intermittent fasting versus 
daily caloric restriction on weight loss and improvement in risk factors associated with 
cardiovascular disease and diabetes. 
 
SEARCH METHODS: We searched MEDLINE, Embase, and CINAHL for published studies 
and clinicaltrials.gov for unpublished results prior to June 28th, 2017.  We also checked 
references lists from previous reviews for possible references to include in this review. 
 
SELECTION CRITERIA: We selected randomized controlled trials of intermittent fasting 
interventions of ≥4 weeks’ duration. We excluded studies that did not explicitly have one day of 
ad libitum feeding per week.  We also excluded studies in cancer patients and in which weight 
loss was not the desired outcome, including Ramadan fasting studies. 
 
DATA COLLECTION AND ANALYSIS: One author independently screened references, 
performed data extraction, risk of bias assessments, and used the GRADE tool to rate the 
strength of evidence underlying each of three Key Questions generated for this review. 
 
RESULTS: We screened titles and abstracts of 1401 studies.  Of these, we reviewed 63 full-text 
articles for inclusion in the systematic review.  After application of inclusion criteria, 10 papers 
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reporting results from 9 studies and 11 intervention groups were identified for inclusion.  In all 
11 reported intermittent fasting groups, participants lost weight.  Based on the reviewed data 
there is moderate strength of evidence in support of an association between intermittent fasting 
and weight loss.  There is very low strength of evidence supporting a difference in efficacy 
between intermittent fasting and daily calorie restriction.  There is also very low strength of 
evidence in support of an association between intermittent fasting and risk factors related to 
cardiovascular disease and diabetes.  Few studies report intermittent fasting-associated harms, 
but those that did reported prevalence of headache and constipation to be 5-13% and 6.5-8% 
respectively, which was not significantly different from control groups.    
 
CONCLUSION: Intermittent fasting is equally effective as, but not superior to, daily caloric 
restriction.  Some patients may find intermittent fasting preferable to traditional weight loss 
strategies.  Further research is needed regarding associations between intermittent fasting and 
risk factors for cardiovascular disease and diabetes, as well as adverse events related to this 
dietary pattern.   
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INTRODUCTION 
 
Background 
Obesity is a public health crisis that has grown in prevalence over the last four decades1 
and is associated with adverse health outcomes including various cancers, cardiovascular 
disease, respiratory disease, and musculoskeletal problems including osteoarthritis.2  In addition, 
obesity disproportionately affects both rural and urban as well as racial and ethnic minorities.1–3  
Not only are these groups more likely to be obese, but they are also less likely to access or 
receive interventions that address obesity.2  For this reason, interventions targeting these 
vulnerable populations are needed. 
Obesity is also associated with significant healthcare expenditures both in the United 
States and worldwide.  According to an analysis by Spieker and Pyzocha, obesity is responsible 
for 20 percent of all health care spending in the United States, with annual directly-associated 
medical costs of $209.7 billion and indirect costs of $66 billion.4  This same analysis found that 
with optimal use of weight loss interventions, obesity-related costs may be reduced by $600 
billion dollars over 20 years.   
Obesity-associated economic impacts include direct medical costs, productivity costs, 
transportation costs, and human capital costs.5 Estimates of direct medical costs include 
treatment for obesity-related diseases such as hypertension and diabetes as well as interventions 
specifically aimed at treating obesity, including bariatric surgery and intensive nutritional and 
educational counseling.  Productivity costs associated with obesity include labor absenteeism, 
premature mortality, and disability as reflected by loss of quality-adjusted life years (QALYs).5  
Additionally, decreased productivity while working, deemed “presenteeism” by Hammond and 
Levine, is another source of obesity-related productivity cost.5 Worker productivity may be 
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negatively impacted by obesity-associated pain, fatigue, and disability. Furthermore, 
transportation costs associated with obesity include higher fuel consumption in airplanes, trains, 
and automobiles, and the increased demand for larger vehicles to accommodate a greater range 
of passenger sizes.   Finally, estimates of human capital costs are based on studies reporting 
associations between obesity and decreased levels of upward mobility as measured by academic 
performance, educational status, and socioeconomic status after adjustment for baseline factors.5–
7 
Despite the health and economic consequences of obesity, there is a paucity of effective 
and broadly implementable interventions, with one recent review suggesting that bariatric 
surgery is the most evidence-based option for treating obesity with associated comorbidities 
including diabetes, gastroesophageal reflux disease (GERD), hypertension, and hyperlipidemia.8  
However, access to bariatric surgery is dependent on health care coverage for the significant 
associated expense, as well as proximity to bariatric surgery services, which tend to be clustered 
in large, academic medical centers.9  Furthermore, bariatric surgery in many cases is irreversible 
and carries the risk of severe adverse events such as bleeding, infection, and failure of 
anastamoses.  Additionally, bariatric surgery is not recommended for individuals with 
overweight body mass index (BMI) of 25-30 or for obese individuals with BMI 30-35 without 
comorbidities, and use in adolescents is controversial.9  For these reasons, bariatric surgery is not 
an ideal first-line treatment for overweight and obese patients. 
Given limited access to bariatric surgery and the lack of highly effective and translatable 
outpatient interventions geared towards obesity, there has been increased attention on novel 
techniques to achieve weight loss.  Interventions have sought to affect change at all levels of the 
Public Health Pyramid, a public health intervention framework that specifies levels of 
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intervention ranging from broad (socioeconomic factors) to specific (counseling and 
education).10  Some of the most widely studied interventions for weight loss include restaurant 
menu labeling, office-based peer support groups, intensive nutritional counseling, excise taxes on 
sugar sweetened beverages, physical activity programs, pharmacotherapy, bariatric surgery, and 
a wide array of complementary and alternative therapies, yet overall evidence is mixed regarding 
the efficacy of these interventions.11–14Caloric restriction is another weight loss strategy that has 
been attempted with conflicting results.  In caloric restriction diets, patients are asked to eat 
fewer than a pre-specified number of calories in a given day, based on basal metabolic rate, sex, 
age, and average daily physical activity level.  Though caloric restriction is associated with 
weight loss, this finding is inconsistent, and there appears to be a significant propensity for 
patients to regain weight even after successful periods of weight loss.13  Reasons that traditional 
caloric restriction diets may be limited in efficacy include the constant requirement to exercise 
self-control and track calories. The difficulty of losing weight by caloric restriction highlights the 
need for weight loss strategies that are both flexible for individual needs and that can be 
incorporated into patient lifestyles even after the weight loss phase of a dietary change.  
 
Intermittent Fasting as a Weight Loss Intervention 
One possible alternative to traditional caloric restriction is intermittent fasting.  
Intermittent fasting is similar to traditional caloric restriction in that it is designed to reduce the 
average number of calories consumed over a given time.  However, unlike traditional caloric 
restriction, intermittent fasting employs techniques of limited meal skipping and fasting days, 
during which as few as 500 calories may be consumed.15,16  These days are interspersed with ad 
libitum feeding days.  Advantages of this approach include having days on which participants do 
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not feel like they are on a restrictive diet and disruption of the addictive neurochemical pathways 
that have been associated with hyperphagia.15,16  Similarly, intermittent fasting may also 
encourage mindful and appreciative eating patterns that persist beyond the period of caloric 
restriction.  Another advantage is that intermittent fasting can be maintained on a limited basis 
after the weight loss phase of a diet, possibly contributing to sustained weight loss, although 
studies of this outcome have not been described in the literature. 
A wide variety of intermittent fasting approaches have been reported.  In one specific 
strategy called alternate day fasting (ADF), participants consumed 25% of their baseline caloric 
intake on alternating days interspersed with ad libitum feeding days, with all caloric consumption 
on fast days occurring between 12:00pm and 2:00pm.17 Other intermittent fasting regimens 
include daily meal skipping (skipping one meal per day, often breakfast) or abstaining from all 
caloric intake for at least 12 hours in a given 24 hour period.18 This strategy of eating within a 
small window of time each day is also called time-restricted feeding. Other studies have been 
conducted in participants fasting daily during religious or spiritual events such as Ramadan.19  
Recognizing that there may be an addictive component in overeating is an important 
factor in preventing and treating obesity.20   Based on an addiction model of overeating, several 
mechanisms have been proposed by which fasting-based diets may lead to weight loss either 
differently or more effectively than daily caloric restriction diets.  In one small trial central μ-
opioid receptor characteristics were shown to change based on whether the participants were in 
fasting or fed states, suggesting that food intake may acutely increase addictive food-consuming 
behavior.21 Similarly, food intake appears to activate the mesocorticolimbic dopamine system, 
which may contribute to feelings of pleasure and satiety.22  In one study, Wang et al. found that 
dopamine D2 receptor expression was lower in obese participants, suggesting that obese 
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individuals may have to overeat to achieve a level of satiety sufficient to quell hunger.23  Wang 
et al. also hypothesized that downregulation of D2 receptors in chronic overeaters may contribute 
to addictive eating behavior,24 possibly illuminating a mechanism whereby periodic caloric 
deprivation as part of an intermittent fasting diet might re-sensitize the mesocorticolimbic 
dopamine system to postprandial stimulation.  Similarly, decreased sensitivity to the satiety-
promoting hormone leptin may play a role in obesity, as obese populations have elevated leptin 
concentrations relative to normal-weight controls despite lower satiety.25  Calorie restriction and 
weight loss decrease leptin levels, which in turn causes hunger to increase. However, the 
breaking of short duration fasts in humans appears to return leptin levels to baseline,26 which 
may promote satiety in individuals attempting to lose weight.           
 Several animal studies suggest that intermittent calorie restriction may alter expression 
of obesity-related genes and influence production of hormones involved in satiety and fullness.  
Long-term caloric restriction and fasting in rats suppresses adipose tissue expression of UCP-1, a 
thermoregulatory gene associated with obesity in humans.27,28 Although suppression of UCP1 
may decrease rate of weight loss, the effect of UCP1 suppression may be smaller with fasts of 
shorter duration such as those that comprise a regimen of intermittent fasting.29 Similarly, the 
concentration of the satiety-promoting hormone leptin decreases in calorie-restricted rats, though 
Kim et al. showed this could be avoided by cycling fasting and feeding, which was found to 
increase leptin levels.30     
Although it is plausible that intermittent fasting may cause weight loss either more 
rapidly or consistently than traditional daily calorie restriction, human trials suggest the 
difference between the two dietary patterns is equivocal.17,31–33   In addition to weight loss, 
studies have reported associations between intermittent fasting and changes in fasting plasma 
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glucose, hemoglobin A1C, blood pressure, and lipid profile,34–36 though no consistent 
associations between fasting and these outcomes have been reported.   
 
Rationale for Systematic Review 
Findings from clinical trials and observational studies have been summarized in three 
systematic reviews, all of which concluded that intermittent fasting and daily caloric restriction 
are similarly effective approaches to weight loss.15,16,37  However, these reviews have included 
observational studies with high risk of bias or have applied inclusion criteria that do not 
effectively differentiate intermittent diet patterns with daily caloric restriction diets.  For 
example, two systematic reviews included studies of very low calorie diets in which participants 
were asked to restrict caloric intake for up to five weeks in a row without days of non-fasting or 
ad libitum intake.16,37  Although there are currently no clear criteria to define intermittent fasting, 
the appeal of this pattern of eating is to reduce the constant need for restriction often experienced 
by dieters. These same reviews also included pre-post observational studies with critically high 
risk of bias according to Cochrane Foundation guidelines.38 In addition, it is unclear whether 
Horne et al. used a comprehensive literature search strategy.  None of these reviews 
systematically addressed intermediate outcomes related to cardiovascular disease or diabetes, 
and none reported the occurrence of adverse events across included studies.   
To facilitate addressing these data gaps we designed three key questions based on the 
populations, interventions, comparators, outcomes, and study designs of interest.  Key Question 
1 for this systematic review focused on weight loss: “In overweight and/or obese adults, does 
intermittent fasting compared with traditional caloric restriction and/or non-intervention result 
in lower weight and/or BMI?”  Key Question 2 was focused on intermediate outcomes related to 
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type 2 diabetes mellitus: “In overweight and/or obese adults, does intermittent fasting compared 
with traditional caloric restriction and/or non-intervention reduce hemoglobin A1c or fasting 
plasma glucose?”  Key Question 3 was focused on intermediate outcomes related to 
cardiovascular disease risk factors: “In overweight and/or obese adults, does intermittent fasting 
compared with traditional caloric restriction and/or non-intervention increase high-density 
lipoprotein or decrease low-density lipoprotein, and/or triglycerides?” For all of the key 
questions, we reviewed data from randomized controlled trials and observational longitudinal 
cohort studies.    
 
METHODS 
 
Protocol and Registration 
 A review protocol was developed for this systematic review but is currently unpublished.  
This review is not currently registered, although the review protocol is being prepared for 
possible submission to the International Prospective Register of Systematic Reviews 
(PROSPERO).       
  
Eligibility Criteria 
 We only considered observational cohort studies and randomized controlled trials for 
inclusion in this review.  Eligible populations for all three Key Questions included adults 18 year 
of age or older who were overweight and/or obese, defined as BMI ≥25 kg/m2.  We did not 
include studies if they reported outcomes in children (<18 years of age) or exclusively non-
obese/overweight patients because results of such studies may have limited external validity in 
obese adult populations.  For Key Questions 2 and 3, we did not limit the eligible study 
population to individuals with diabetes or cardiovascular disease, as the intermediate endpoints 
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of interest are readily measurable in individuals without these conditions, and there are scarce 
data on intermittent fasting in these patient populations.   We excluded from this review studies 
reporting outcomes of fasting in cancer patients, as malignancy is a confounder of weight loss 
and fasting interventions in cancer patients are designed to slow cancer growth, not to decrease 
weight.  We also excluded studies performed in populations observing Ramadan, as Ramadan 
fasting is not explicitly intended as a weight loss intervention.  Furthermore, Ramadan lasts one 
full month, and the inclusion criteria for this review necessitate at least one non-fasting ad 
libitum feeding day per week.  
 For all three Key Questions, the intervention of interest was intermittent fasting, defined 
as at least 12 hours without caloric intake OR at least 24 hours w/ ≥50% reduction in baseline 
caloric requirement.  We excluded studies that did not include ad libitum eating periods, as a 
fundamental component of intermittent fasting interventions is the ability to eat without 
restriction during non-fasting periods.  Furthermore, we excluded studies that did not have an ad 
libitum feeding component at least once per week. This excluded studies of very low calorie diets 
(VLCDs) that do not necessitate alternating periods of caloric restriction and ad libitum intake, 
but nonetheless may have alternating components.  For example, one VLCD diet regimen 
includes continuous eight week VLCD intervals,39 and another includes alternating VLCD and 
ad libitum periods lasting five weeks.40  Given that a major advantage of intermittent fasting is 
permitting participants to have “off days” during which they do not feel the pressure to limit their 
food intake, it is important to exclude studies of VLCDs that do not have an intermittent 
component at least once weekly.  We did not specify a minimum frequency of fasting for 
inclusion in this review, as some interventions are based on monthly or semi-monthly fasting 
regimens.41  
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 For all three Key Questions, the comparator groups were either traditional caloric 
restriction or non-intervention.  We defined non-intervention as any intervention not designed 
directly to reduce weight, including education-only control groups, support groups, intensive 
dietary counseling, and treatment with placebo weight loss pills, or representative populations 
that did not undergo a form of intermittent fasting.  We included any intervention-based 
comparator group if it did not meet the inclusion criteria for intermittent fasting as described 
above. 
Studied outcomes for Key Question 1 included weight change (measured in pounds 
and/or kilograms) and BMI change (reported in kg/m2).  We only considered for inclusion time 
points inclusive of the active intervention, as some studies report continuing weight loss and 
weight maintenance during non-intervention follow-up periods, and the efficacy of dietary 
interventions in producing weight maintenance is beyond the scope of this review.  For Key 
Question 2, intermediate outcomes related to diabetes included hemoglobin A1c and fasting 
plasma glucose (FPG).  For Key Question 3 intermediate outcomes related to cardiovascular 
disease included levels of high-density lipoprotein (HDL), low-density lipoprotein (LDL) and 
triglycerides (TG).   
Given that our review is designed to assess the efficacy of intermittent fasting as a long-
term weight loss intervention, we excluded studies of interventions lasting less than four weeks. 
For lipid profile outcomes and for hemoglobin A1c, we only included studies of ≥4 weeks 
duration, as changes in these outcomes require additional time to occur. Specific population, 
intervention, comparator, outcome, timing, setting, and study design (PICOTSS) criteria for each 
Key Question are listed in Table 1. 
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Table 1. Population, Intervention, Comparator, Outcome, Timing, Setting, and Study Design 
(PICOTSS) for the three Key Questions assessed in this systematic review of intermittent fasting 
 Key Question 1: 
Weight Loss 
Key Question 2: 
Intermediate Outcomes 
Related to Diabetes 
Key Question 3: Intermediate 
Outcomes Related to 
Cardiovascular Disease 
Population 
Overweight/obese 
(BMI≥25 kg/m2) 
adults (age≥18 
years) 
Overweight/obese 
(BMI≥25 kg/m2) adults 
(age≥18 years) 
Overweight/obese (BMI≥25 
kg/m2) adults (age≥18 years) 
Intervention 
Intermittent fasting 
(at least 12 hours 
without caloric 
intake OR at least 
24 hours w/ ≥50% 
reduction in caloric 
intake) 
Intermittent fasting (at 
least 12 hours without 
caloric intake OR at least 
24 hours w/ ≥50% 
reduction in baseline 
caloric intake) 
Intermittent fasting (at least 12 
hours without caloric intake 
OR at least 24 hours w/ ≥50% 
reduction in baseline caloric 
intake) 
Comparator 
Traditional caloric 
restriction and/or 
non-intervention or 
other control group 
Traditional caloric 
restriction and/or non-
intervention or other 
control group 
Traditional caloric restriction 
and/or non-intervention or 
other control group 
Outcomes 
Weight (lbs/kgs), 
BMI (Kg/m2) 
Hemoglobin A1c 
(HgbA1c), fasting plasma 
glucose (FPG)  
High-density lipoprotein 
(HDL), low-density 
lipoprotein (LDL), 
triglycerides (TG) 
Timing 
≥4 weeks ≥4 weeks for fasting 
insulin, and/or insulin 
resistance. ≥4 weeks for 
HgbA1c 
≥4 weeks for blood pressure, ≥ 
4 weeks for cholesterol, high-
density lipoprotein, low-
density lipoprotein, and/or 
triglycerides 
Setting 
University research 
centers, outpatient 
clinics, community 
based interventions 
University research 
centers, outpatient clinics, 
community based 
interventions 
University research centers, 
outpatient clinics, community 
based interventions 
Study 
Design 
Randomized 
controlled trials, 
longitudinal cohort 
studies 
Randomized controlled 
trials, longitudinal cohort 
studies 
Randomized controlled trials, 
longitudinal cohort studies 
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Literature Search Strategy 
We conducted formal literature searches via MEDLINE, EMBASE, and CINAHL, and 
additional queries were made with The Cochrane Database of Systematic Reviews and 
GoogleScholar between January 15th, 2017 and June 28th, 2017.  We also searched 
clinicaltrials.gov on June 28th, 2017 for grey literature including unpublished studies and results. 
Literature published after June 28th, 2017 was therefore not included in this review.  We 
considered additional sources based on review of references used in the papers discovered 
through the initial search. We designed search strings based on the PICO factors for each key 
question.  The full search strings, including the list of synonyms used to search MEDLINE, 
EMBASE, and CINAHL are shown in Appendix 1.   
 
Study Selection and Data Extraction 
 One author (RA) independently assessed all titles and abstracts identified by the literature 
search.  For papers deemed potentially eligible by title/abstract review, RA obtained and 
reviewed the full text.  All studies meeting the pre-specified eligibility criteria were included.   
RA extracted data into Microsoft Word tables designed specifically for this review.  
Extracted data included sample size (N), study duration, post-intervention values for weight 
change (kg), HgbA1c, FPG, HDL, LDL, and triglycerides.  Given that these values were 
continuous, we included means and standard deviations when reported by the included studies.  
When possible we also included prevalence (percent, or proportion converted to percent, and 
standard deviation) of adverse outcomes including headache, nausea, compensatory binge eating, 
hunger, fullness, and constipation in the intervention vs. nonintervention groups.   
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Risk of Bias in Individual Studies 
 One author (RA) assessed each included study for risk of bias.  Bias assessments were 
conducted using the Cochrane Risk of Bias Tool as specified in the The Cochrane Handbook for 
Systematic Reviews and Interventions.38 Risk of bias was assessed based on six domains, 
including: 1.) allocation sequence generation, 2.) concealment of allocation, 3.) blinding of 
participants and investigators, 4.) incomplete outcome data, 5.) selective outcome reporting, and 
6.) other bias sources.  Within each domain, we scored studies as having low, high, or unclear 
risk of bias.  Pre-post studies or uncontrolled observational studies were excluded based on 
having critical risk of bias, in accordance with Cochrane guidance.38  
 
Data Synthesis and Summary Measures 
 We did not perform imputations for missing data, and we did not contact authors of 
studies reporting missing data.  Using the GRADE approach42 we combined information on 
internal validity (risk of bias, inconsistency, imprecision, publication bias) and external validity 
(directness of results, applicability to patient populations) to characterize the overall quality of 
evidence supporting the efficacy of intermittent fasting in changing each outcome variable.    
       
RESULTS 
 
Study Selection 
 After removal of duplicates, our initial literature search identified 1395 titles and 
abstracts, and 6 additional references were added through reference review of the identified 
publications as well as literature searches conducted via GoogleScholar; in total 1401 references 
were identified for possible inclusion in this review.  1338 records were excluded on the basis of 
title and abstract, with reasons for exclusion being: acute study duration (n=19), animal studies 
 16 
 
or studies of dietary interventions that did not meet inclusion criteria for this review based on 
frequency or duration of fasting (n=905), studies in children (n=10), non-English language 
publications (n=19), studies of Ramadan participants (n=36), and non-experimental references 
such as other reviews, case studies, or conference abstracts (n=349). 
We reviewed 63 full-text articles for eligibility.  Of these, we excluded studies on the 
basis of not meeting inclusion criteria for intermittent fasting (n=24); reviews, case studies, or 
conference abstracts that were not identified with the initial title/abstract screen (n=16); studies 
in which weight loss was not the objective of the intervention (n=6); studies that did not report 
the outcomes included in this systematic review (n=1) and; studies with critical risk of bias 
(n=6). Even though it did not explicitly violate inclusion criteria, we excluded a study by Lantz 
et al.43 because the frequency of fast days in the “on-demand” weight loss group was not 
reported, and therefore it was not possible to ascertain whether there was at least one fasting day 
per week of intervention.   After review by full text, we found 10 papers reporting on 9 
randomized controlled trials that fully met inclusion criteria for this review.  The PRISMA flow 
diagram outlining the results of our literature search is shown in Figure 1.  
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Figure 1. PRISMA flow diagram indicating identification and inclusion of references for 
systematic review    
 
 
Characteristics and Results of Included Studies 
 Results from included studies are summarized herein, but full data extraction tables are 
available in Appendix 2.  Ash et al.44 conducted a randomized trial in overweight men with type 
2 diabetes in which participants were randomized to one of three experimental groups. The two 
experimental groups included one intermittent energy restriction group and a group given 
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predetermined meals with a set number of calories. The latter group was not included in this 
systematic review, as the predetermined meal intervention did not fit the inclusion criteria for 
interventions or controls.  The control group was allowed to self-select dietary pattern but was 
required to adhere to the same average caloric intake as the experimental groups.  After twelve 
weeks, participants in the control group and the experimental group lost 6.4+/-4.6 Kg on average, 
and the difference between the two groups was not statistically significant.  Triglycerides 
decreased by 3.6mg/dL across the two groups, and hemoglobin A1c decreased by 1.2%.  Given 
that none of the differences were significant across groups, the study authors reported only mean 
changes in outcomes across both control and experimental groups.   
Bhutani et al.45,46 performed a randomized controlled trial in 41 obese adults between the 
ages of 25 and 65 examining the role of intermittent fasting and exercise interventions on weight 
loss.  There were two experimental groups; both participated in an intermittent fasting regimen 
comprised of 25% of baseline calorie consumption on alternating days, with ad libitum feeding 
allowed on non-fasting days.  In one of the two experimental groups, participants were also 
required to complete moderate-intensity endurance exercises three times per week.  The 
fasting+exercise group was compared to an education+exercise control group, while the fasting-
only group was compared to an education-only group.  After 12 weeks, subjects in the 
intermittent fasting+exercise group lost -6+/-4 kg, compared to -1+/-0 kg in the exercise-only 
control group.  The difference between the experimental and control exercise groups was not 
statistically significant.  However, there was a significant difference between the intermittent 
fasting-only group and the group of education-only controls, with weight loss of 3+/-1 kg and 
0+/-0 kg respectively.  There was also a significant increase in HDL in the fasting+exercise 
group relative controls, but there were no other significant differences between experimental and 
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control groups. The authors also reported on diet-associated hunger, fullness, and uncontrolled 
eating.  In fasting groups, hunger decreased and fullness increased over the 12 week study.  
Uncontrolled eating decreased in the fasting and fasting+exercise groups. 
Carter et al.34 randomized 63 overweight and obese adults with type 2 diabetes to either 
an experimental group that fasted twice per week or a control group that was administered a 
daily calorie restriction diet capped at 1200-1550 kcal/day.  On fast days participants were 
permitted consumption of up to 400-600 calories, dependent on baseline calculated caloric need, 
while on non-fasting days participants were allowed to eat ad libitum.  After 12 weeks, both 
groups lost 8 kg of weight.  The study authors also reported change in HgbA1c, which decreased 
by 0.6% in the fasting group and 0.8% in the control group, though this difference was not 
statistically significant.  Carter et al. also reported on diet-associated hunger and fullness; control 
and experimental groups both reported decreases in hunger and increased fullness over the 
twelve weeks of the study. 
In one study of overweight and obese patients with family history of breast cancer, 
Harvie et. al.33 randomized 107 women to one of two diets: a control diet of daily caloric 
restriction of 75% of calculated need and an experimental diet comprised of two fasting days per 
week.  On fasting days, participants were asked to consume fewer than 645 calories and to aim 
for 50g of total protein consumption.  At the end of 26 weeks, the intermittent fasting group had 
lost 5.7 kg compared to 4.5 kg in the control group, though this difference was not statistically 
significant.  In the intermittent fasting group, LDL-c decreased by 11.6mg/dL and triglycerides 
by 18mg/dL.  HDL cholesterol was unchanged, and none of these differences were significant 
between groups. 
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Harvie et al. conducted a second similarly designed study47 in which 36 overweight and 
obese women between the ages of 20 and 69 and with positive family history of breast cancer 
were randomized to one of two diets.  The control diet was comprised of standard caloric 
restriction of 75% of calculated daily energy requirement.  The experimental group was asked to 
fast on two fasting days per week (a 5:2 regimen), with caloric intake on fast days capped at 30% 
of calculated daily caloric need.  Furthermore, participants were limited to 40g of carbohydrates 
on fast days.  After 12 weeks, the fasting group had lost 5.0 kg on average compared to 4.0 kg in 
the control group, though this difference was not statistically significant.  Similarly, there were 
no statistically significant differences between any of the reported cardiovascular or diabetes 
risk-related endpoints. 
The two included studies by Harvie et al. also reported on adverse events experienced 
during the course of the trial.  Decreased energy was reported by 5% of the intermittent fasting 
group and 5% of the daily calorie restriction control group.  Constipation occurred in 8% of 
intermittent fasters vs. 3% of controls.  Headache occurred in 5% of the intermittent fast group 
and 0% of controls.  Light-headedness occurred in 3 vs. 0% (fasting vs. controls) and mood 
instability was reported in 3% of intermittent fasting participants but 5% in the control group.  
Finally, halitosis was reported by 5% of participants in the fasting group vs. 3% in controls.  
Overall, there were more events reported in the fasting group, though none of these differences 
from controls reached statistical significance.  
Hill et al.48 performed a randomized controlled trial in which 40 moderately obese 
women were assigned to a regimen of alternate daily fasting intervention or daily caloric 
restriction.  Both groups had a subgroup of participants who were asked to exercise by walking 5 
days per week.  All diets provided an average of 1200 kcal/day over a 12 week period, and all 
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participants also received an educational program.  At the end of the study, all participants 
engaging in intermittent fasting had lost 7.6 kg, while the control group lost 7.6 kg also.  Hill et. 
al did not report outcomes related to cardiovascular disease or diabetes. 
Varady et al.35 compared the effects of daily caloric restriction with those of alternate 
daily fasting on weight and cardiovascular disease risk factors.  They performed a randomized 
controlled trial in 30 overweight and obese adults age 35-65 with no history of cardiovascular 
disease, diabetes, or smoking.  Participants were randomized to an intervention group that fasted 
every other day for 84 days or to a control group that was prescribed a daily calorie restriction 
diet comprised of 75% of baseline daily caloric need.  Absolute weight loss was not reported in 
this study; however, participants in the intervention group lost 5.2+/-1.1 percent of their baseline 
body weight, while participants in the control group lost 5.0+/1.4 percent, a difference that was 
not statistically significant.  Varady et al. similarly reported cardiovascular disease risk factor 
changes as percent change instead of absolute change.  The only statistically significant 
difference in cardiovascular disease risk factors for the control vs. intervention group was in 
LDL cholesterol, which decreased by 10+/-4 percent in the intervention group and by 8+/-4 
percent in the control group.  Differences in HDL and triglyceride change were not significant, 
though small improvements were seen in both groups.  The study authors also reported adverse 
event rates in the fasting intervention group.  Two out of 15 subjects (13%) experienced new-
onset headaches during the course of the study.  One out of 15 intervention subjects (6.5%) 
reported constipation; however, this had resolved by the third week after the participant was 
encouraged to increase fruit and vegetable intake.   
Varady et al conducted a second randomized controlled trial17 of intermittent fasting in 
25 patients who were either normal or overweight (BMI 20-29.99 kg/m2).  Participants were 
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randomized to either an alternate daily fasting regimen on which 25% or fewer of baseline 
calorie needs were consumed between 12:00pm and 2:00pm or a non-intervention group in 
which participants were asked to maintain their regular food consumption habits but had regular 
meetings with nutritionists.  At the end of the 12 week study period, body weight decreased in 
both groups, but the fasting group lost 5.2+/-0.9 kg more than the control group, a difference that 
was statistically significant.    Participants in the alternate daily fasting arm also reported a 
statistically significant decrease in overall fullness over the course of the study, but there were no 
significant differences between the two groups in hunger or satisfaction.  There also were no 
significant differences between the two groups in outcomes associated with cardiovascular 
disease or diabetes risk factors. 
Williams et al.41 performed a randomized controlled trial in 40 individuals with type 2 
diabetes and who were at least 20 percent above ideal body weight.  In this study, a control group 
was treated with standard diet-related behavioral therapy.  There were two fasting interventions, 
both of which started with a period of fasting for five days in one week with 400-600 kcal 
permitted on fasting days.  Then, in the first group, participants spent 15 weeks with one fasting 
day per week.  In the second group, participants were asked to fast for five consecutive days at 
least four times over the remaining 15 weeks.  By study’s end, the group receiving the standard 
behavioral intervention had lost 5.4+/-5.9 kg, while the group that fasted one day per week lost 
9.6+/-5.7 kg, and the group that engaged in four five-day fasting periods lost 10.4+/-5.4.  Weight 
loss in both experimental groups was statistically significant in comparison to controls, but the 
difference in weight loss between the two fasting regimens was not.  There also were  no 
statistically significant differences in cardiovascular disease or diabetes-related outcomes. 
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Synthesis of Results 
In summary there were 9 studies published in 10 papers reporting on 11 experimental 
fasting groups and their reported weight loss.  Among the 11 fasting groups, 6 were compared to 
a daily calorie restriction group as the control, while 5 fasting groups were compared to an 
education-only control group.  Overall, weight loss was reported in all 11 experimental groups, 
and 10 out of 11 control groups.  There were no statistically significant differences in weight loss 
in fasting groups compared to daily calorie restriction control groups, however, when compared 
to education-only controls, 4 out of 5 experimental groups experienced statistically significant 
weight loss.  It was not possible to calculate the average weight lost in experimental vs. control 
groups given the heterogeneity across studies in reporting weight loss values and estimates of 
precision          
Regarding outcomes related to cardiovascular disease and diabetes, there were 8 studies 
published in 9 papers reporting on 10 experimental fasting groups and their reported changes in 
triglycerides, LDL, HDL, HgbA1c, and fasting plasma glucose.  Only the study by Hill et al.48 
did not report these outcomes.  There were few statistically significant differences found between 
intervention and control groups, including those control groups comprised of behavioral or 
education-only interventions.  No trends were observed in changes in these parameters, with 
different studies reporting increases and/or decreases in the same parameters.  Across studies, 
two statistically significant results were reported.   Bhutani et al.45,46  found a statistically 
significant increase in HDL in a fasting+exercise experimental group compared to fasting-only 
and exercise-only groups (+9 vs. +4 mg/dl). Varady et al.35 reported statistically significant 
differences between fasters and controls in LDL (respectively, -10+/-4% vs. -8+/-4%) and 
triglycerides (respectively -15+/-12% vs. +10+/-12%) at the end of 12 weeks.   
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Adverse outcomes were reported in 4 of the 10 included publications, including Harvie et 
al.,47 Bhutani et al.,46 Carter et al.,34 and Varady et al.17  Outcomes described in more than one 
study include constipation, headache, and hunger.  The rate of constipation in fasting groups 
ranged from 6.5%-8% vs. 0%-3% in controls, and for headache from 5%-13% in fasting groups 
vs. 0% reported in controls.  Qualitative hunger was reported to decrease in two studies.  Full 
data for adverse outcomes are available in Appendix 2   
Based on our analysis using the GRADE instrument, the overall quality of evidence 
supporting a difference between intermittent fasting and education-only non-intervention groups 
is moderate.  In all 9 randomized controlled trials including 244 participants, the intermittent 
fasting interventions produced weight loss.  There was a consistent trend of statistical 
significance across studies supporting an association between intermittent fasting and weight loss 
in comparison to populations treated only with behavioral or educational interventions. The 
overall quality of evidence supporting a difference between intermittent fasting interventions and 
daily caloric restriction for weight loss is low due to small sample sizes and inconsistently 
observed effects.  Similarly, the overall evidence for associations between intermittent fasting 
and changes in cardiovascular disease and diabetes endpoints is constrained by small sample 
sizes and inconsistently observed effects. A summary table describing our findings with the 
GRADE assessment is shown in Table 2. 
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Table 2. Summary of strength of evidence for selected outcomes of this review in accordance with the Grading of Recommendations 
Assessment, Development, and Evaluation (GRADE) approach.  +=Very low strength of evidence; ++=Low strength of evidence; 
+++=Moderate strength of evidence; ++++=High strength of evidence 
Outcome Fasting 
(n) 
Daily Energy 
Restriction (n) 
Non- 
intervention (n)  
Total No. of 
participants 
(n) 
Quality of Evidence 
(GRADE) Fasting vs. 
daily calorie restriction 
Quality of Evidence 
(GRADE) Fasting vs. 
non-intervention 
Change 
in weight 
244 152 91 487 + +++ 
Change 
in LDL 
224 132 91 447 + + 
Change 
in HDL 
224 132 91 447 + + 
Change 
in TG 
224 132 91 447 + + 
Change 
in 
HgbA1c 
224 132 91 447 + + 
Change 
in FPG 
224 132 91 447 + + 
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Assessment of Risk of Bias 
 We assessed the included studies for risk of bias using the Cochrane Risk of Bias Tool.  
Results are shown in Table 3.  The overall risk of bias is unclear due insufficient reporting on 
blinding of outcome assessment and other potential sources of bias including conflicts of interest.  
All included studies had either a low or unclear risk of selection bias related to random sequence 
generation or allocation concealment.  All included studies were considered high risk of 
performance bias due to the insufficient blinding of participants and personnel; in no studies 
were participants blinded to dietary intervention.  Similarly, all but one study was rated an 
unclear level of detection bias.  Study personnel performing assessments were blinded in one of 
the 9 included trials.   The risk of attrition bias due to incomplete outcome data was deemed to be 
low in 8 of 9 of the included studies.  The study that was rated as “unclear” risk of attrition bias 
did not report comparability of dropout between groups and did not use intention-to-treat 
analyses.  Reporting bias due to selective reporting was difficult to assess because 7 of the 9 
included trials did not have clinical trial registry data available for comparison.  One study was 
deemed high risk of selective reporting bias because changes from baseline to 12-weeks of 
intervention were not reported for both groups; outcomes were pooled and average weight loss 
was reported. Justifications for our reported risk of bias for each included study are available in 
Appendix 3. 
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Table 3. Risk of bias in included studies.  For each study, selection bias, performance bias, detection bias, attrition bias, reporting bias, and other bias 
was rated as “High,” “Low,” or “Unclear.”  Full ratings with justifications are available in Appendix 3. 
Reference Random 
Sequence 
Generation 
(Selection 
Bias) 
Allocation 
Concealment 
(Selection Bias) 
Blinding of 
Participants and 
Personnel 
(Performance 
Bias) 
Blinding of 
Outcome 
Assessment 
(Detection Bias) 
Incomplete 
Outcome Data 
(Attrition Bias) 
Selective 
Reporting 
(Reporting 
Bias) 
Other Bias 
Ash et al. Low Unclear High Unclear Low High Unclear 
Bhutani et al. Low Low High Unclear Low Unclear Unclear 
Carter et al. Low Low High  Unclear Low Low Unclear 
Harvie et al. 
Study 1 
Unclear  Unclear High Unclear Low Unclear Unclear 
Harvie et al. 
Study 2 
Unclear  Low High Low Low Unclear Unclear 
Hill et al. Unclear Unclear High Unclear Unclear Unclear Unclear 
Varady et al. 
Study 1 
Unclear Unclear High Unclear Low Unclear Unclear 
Varady et al. 
Study 2 
Low Unclear High Unclear Low Unclear Unclear 
Williams et al Unclear Unclear High Unclear Low Unclear Unclear 
 
 28 
 
DISCUSSION 
 
Intermittent Fasting as a Dietary Intervention for Weight Loss 
 Key Question 1 for this systematic review focused on weight loss: “In overweight and/or 
obese adults, does intermittent fasting compared with traditional caloric restriction and/or non-
intervention alter weight and/or BMI?” Based on the results of this systematic review there is 
moderate evidence supporting the efficacy of this intervention for weight loss in comparison to 
behavioral-only or education-only interventions.  However, we found that the quality of evidence 
supportive of a difference between daily caloric restriction and intermittent fasting is very low 
overall.  No studies reported statistically significant differences between the two diets and there 
was substantial heterogeneity, small sample size, and small effect sizes. 
 The finding that daily caloric restriction is comparable in efficacy to intermittent fasting 
is consistent with those of previous systematic reviews.  The review by Davis et al.16 found that 
all included studies reported significant weight loss in intermittent fasting groups and that 
intermittent energy restriction diets did not appear to differ in their efficacy for weight loss when 
compared to traditional caloric restriction diets.  Similarly, Seimon et al.37 found that intermittent 
fasting was equivalent, but not superior to traditional daily caloric restriction, and this 
relationship was true for both long-term interventions such as those included in this review and 
short term interventions lasting fewer than four weeks.  Horne et. al.15 also published a 
systematic review on intermittent fasting, however their literature search strategy was unclear 
and included only five studies, some of which were based on Ramadan fasts not explicitly 
intended to cause weight loss.  Nonetheless, Horne et al. found results similar to those of this 
review, reporting that intermittent fasting appears to be efficacious for weight loss but is not 
significantly different from daily caloric restriction in this regard.  All three of these systematic 
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reviews included studies reporting on very-low calorie diets, which were excluded in this 
systematic review based on lacking an intermittent component.  Nonetheless, the results of this 
review add to a growing body of evidence that intermittent fasting diets may be an effective 
alternative to daily caloric restriction for patients attempting to lose weight. 
The availability of alternative weight loss strategies for patients attempting weight loss is 
important clinically.  In busy clinical settings, physicians tend to rely on simple, well-known 
dietary interventions such as daily caloric restriction, yet current success rates of these traditional 
dietary interventions for long-term weight loss are approximately 20%.49 This highlights the 
importance of customizing dietary approaches to individual preference, particularly for patients 
with addictive patterns of eating for whom daily caloric restriction may not be an ideal strategy 
to lose weight.  As an analogy, the “cold turkey” approach is considered an effective way to quit 
smoking,50 and for many smokers the notion of reducing cigarette consumption but not quitting 
outright is more daunting than stopping altogether.  For addictive eaters there may be some 
similarity in the sense that food consumption, which is necessary for survival, is itself a trigger 
for additional eating.  For this reason, intermittent fasting may represent the best middle ground 
between the diet fatigue associated with daily calorie counting and a theoretical “cold turkey” 
method.    In summary, the shortcomings of daily caloric restriction may be mitigated through 
use of an intermittent fasting diet.  Regardless, of the intervention used, successful weight loss 
necessitates a comprehensive, multidisciplinary approach.51   
   
Intermittent Fasting to Minimize Cardiovascular Disease and Diabetes Risk Factors 
 Key Question 2 for this systematic review focused on intermediate outcomes related to 
type 2 diabetes mellitus: “In overweight and/or obese adults, does intermittent fasting compared 
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with traditional caloric restriction and/or non-intervention alter hemoglobin A1c and/or fasting 
plasma glucose?”  Similarly, Key Question 3 focused on intermediate outcomes related to 
cardiovascular disease risk factors: “In overweight and/or obese adults, does intermittent fasting 
compared with traditional caloric restriction and/or non-intervention alter high-density 
lipoprotein, low-density lipoprotein, and/or triglycerides?”  Based on the results of this 
systematic review, the strength of evidence supporting a relationship between intermittent fasting 
and these outcomes is very low overall.  This is primarily due to widespread heterogeneity of 
results, small sample sizes, and small effect sizes.  The strength of evidence is similarly very low 
regarding a possible difference between intermittent fasting and daily caloric restriction in terms 
of these outcomes. 
Of the three identified previous systematic review on intermittent fasting, only Horne et 
al.15 reported on an association between intermittent fasting and cardiovascular disease risk 
factors.  They included two observational studies on intermittent fasting and coronary artery 
disease risk factors, both of which were excluded from this review due to critical risk of bias.  
The authors conclude that further research is needed to determine whether intermittent fasting is 
associated with changes in risk factors for cardiovascular disease and diabetes.  The evidence in 
our review is supportive of this conclusion; studies included reported small sample sizes that 
were likely insufficient to detect a significant effect on these outcomes. The systematic review 
by Davis et al. did not include outcomes related to diabetes or cardiovascular disease, however, 
the authors based their decision to exclude these data on the apparent lack of statistical power in 
existing studies.16   
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Intermittent Fasting and Adverse Outcomes 
 Of the 9 studies included in this review, four reported on adverse outcomes and events, 
although reporting was inconsistent and sample sizes were insufficient to detect significant 
differences.  The most commonly reported adverse effects of intermittent fasting diets appear to 
be headache, constipation, and decreased energy, although these occur with similar frequency in 
the daily calorie restriction groups.  Interestingly, hunger appears to decrease with intermittent 
fasting interventions.  No studies reported on anorexia, binge eating, or bulimic behaviors in 
intervention arms, however, a previous study found an association between engaging in fasts and 
bulimia,52 although the direction of causality was unclear based on the cross-sectional study 
design.  Another systematic review found that daily caloric restriction reduced prevalence of 
binge-eating disorder in experimental groups.53.  There are limited data specifically regarding the 
safety and tolerability of intermittent fasting as an intervention for weight loss. However, 
emerging expert opinion is supportive of the notion that intermittent fasting is comparable to 
daily caloric restriction in terms of adverse outcomes and that adverse outcomes are collectively 
uncommon unless a fasting intervention is implemented in normal weight participants attempting 
further weight loss.32,54,55  
 
Limitations and Future Directions 
 This review has several limitations.  Due to logistical limitations, studies of intermittent 
fasting that were published in other languages were not included in this review.  These constitute 
a potentially important source of information on the efficacy and/or harms of intermittent fasting 
interventions, particularly given the rising prevalence of obesity in developing nations.56 
Additionally, only one author reviewed titles, determined inclusions, and assessed risk of bias. 
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Another limitation of this study was the limited inclusion of possible markers of cardiovascular 
disease and diabetes.   Given that the results of this review might be used by clinicians to counsel 
patients about weight loss strategies, we did not include infrequently used or difficult-to-obtain 
laboratory measurements such as fasting insulin, insulin sensitivity, and LDL and HDL particle 
size.  These may be significant markers of disease risk or progression but are not part of routine 
laboratory evaluation for these diseases and so were not included in this review. This review may 
also be limited in external validity, as it is unclear if these findings are externally valid to 
populations that may be vulnerable based on race, ethnicity, socioeconomic status, gender, sex, 
and/or geography.   Finally, we were unable to perform a meta-analysis with included data due to 
heterogeneity of reporting and inadequate availability of measures of precision in the included 
studies.   
 In part, the limitations of this review are attributable to evidence gaps in the literature.  
Overall, sample sizes in the included studies are small, and there is a paucity of data on 
intermittent fasting as an intervention in specific subpopulations, particularly racial and ethnic 
minorities.  In addition, all of the included studies took place in resource-rich university settings 
where participants had access to behavioral counseling, nutritionists, and high quality food 
sources.  It is unclear if individuals attempting weight loss in underserved and/or rural areas, 
where the obesity epidemic is particularly problematic, would achieve similar weight loss 
outcomes, and future studies of intermittent fasting should assess interventions that may have 
greater external validity or are easier to implement. There may also be varied efficacy of 
intermittent fasting as an intervention in subgroups with specific patterns of overeating, such as 
addictive or binge eaters,57 but efficacy of intermittent fasting in these groups has not been 
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reported in the literature.  Future studies might better characterize the efficacy of intermittent 
fasting interventions by stratifying participants by eating behavior.   
Overall, the strength of evidence supporting an association between intermittent fasting 
and outcomes related to cardiovascular disease and diabetes is very low.  Several systematic 
reviews and meta-analyses support the notion that weight loss reduces morbidity and mortality in 
obese patients, possibly by 15%,58,59  and much of this reduction is attributable to reductions in 
prevalence of diabetes and cardiovascular disease. However, there are few data reporting 
morbidity and mortality associated with specific weight loss interventions.  Ideally, future studies 
of intermittent fasting and/or daily caloric restriction will be sufficiently powered and of 
sufficient duration to observe morbidity and mortality changes and to accurately measure adverse 
event rates. Absent morbidity and mortality data, it will be helpful for future studies of 
intermittent fasting to be sufficiently powered to detect significant differences in intermediate 
outcomes associated with cardiovascular disease and diabetes, the chief drivers of obesity-
associated mortality.60 
Adverse event reporting is inconsistent across studies, with the majority of studies 
included in this review omitting reporting on such outcomes.  Future studies should include rates 
of constipation, headache, and fatigue in experimental and control groups, as based on this 
review these are the most commonly reported adverse events associated with intermittent fasting.  
Furthermore, studies are needed on the safety of this dietary intervention in groups with history 
of eating disorders such as anorexia, bulimia, and binge-eating disorder, as improper compliance 
with an intermittent fasting diet could contribute to first occurrence or relapse of these 
conditions.  This is of particular importance given that the prevalence of eating disorders in 
obese populations may be increasing.61 
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CONCLUSION 
In summary, the obesity pandemic is an international public health crisis, and novel 
interventions are needed to help obese patients lose weight.   Intermittent fasting is one such 
intervention that affords dieters periods of indulgence interspersed with periods of strict caloric 
restriction, which may improve weight loss compliance for some patients. In this systematic 
review, we assessed the efficacy of intermittent fasting for weight loss in comparison to daily 
caloric restriction, which has long been a mainstay of dietary interventions for patients seeking to 
lose weight.  We also reviewed the evidence supporting an association between intermittent 
fasting and changes in risk factors for cardiovascular disease and diabetes.   In this review, which 
included nine randomized controlled trials, we found moderate strength evidence that 
intermittent fasting is effective for weight loss, though its efficacy for weight loss is 
approximately the same as that of daily caloric restriction.  The overall strength of evidence 
supporting an association between intermittent fasting and changes in risk factors for 
cardiovascular disease and diabetes was very low.  Intermittent fasting-associated adverse events 
reported across studies included headache and constipation, though reporting of adverse events is 
inconsistent across studies, and we found no reports of associations between intermittent fasting 
dietary interventions and unhealthy eating behaviors.   
Collectively, these data support the hypothesis that intermittent fasting is an effective 
alternative to daily caloric restriction, though future studies should be sufficiently powered to 
detect changes in risk factors for cardiovascular diseases and diabetes as well as adverse event 
rates.  Intermittent fasting as an intervention may be preferred by some patients, and clinicians 
should tailor dietary weight loss plans to individual needs.  Like other dietary weight loss 
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interventions, intermittent fasting is most effective when combined with additional lifestyle 
modifications including exercise, counseling, and peer support. 
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APPENDIX 1: Literature Search Strings 
 
MEDLINE Search String (832 Results Identified) 
("Overweight"[Mesh] OR "Obesity"[Mesh] OR ("obesity"[MeSH Terms] OR 
"obesity"[All Fields] OR "obese"[All Fields])) AND ((periodic[All Fields] AND 
("fasting"[MeSH Terms] OR "fasting"[All Fields] OR "fast"[All Fields])) OR (periodic[All 
Fields] AND fasts[All Fields]) OR "periodic fasting"[All Fields] OR "intermittent calorie 
restriction"[All Fields] OR "intermittent fasting"[All Fields] OR "intermittent fasts"[All Fields] 
OR "intermittent fast"[All Fields] OR "intermittent energy restriction"[All Fields] OR 
"intermittent caloric restriction"[All Fields] OR "Very low calorie diet"[All Fields] OR "very 
low calorie diets"[All Fields] OR "continuous energy restriction"[All Fields] OR "time restricted 
feeding"[All Fields] OR (("time"[MeSH Terms] OR "time"[All Fields]) AND restricted[All 
Fields] AND feeds[All Fields]) OR (("time"[MeSH Terms] OR "time"[All Fields]) AND 
restricted[All Fields] AND feed[All Fields])) AND ("Body Mass Index"[Mesh] OR "Ideal Body 
Weight"[Mesh] OR "body weight"[All Fields] OR ("weights and measures"[MeSH Terms] OR 
("weights"[All Fields] AND "measures"[All Fields]) OR "weights and measures"[All Fields] OR 
"weight"[All Fields] OR "body weight"[MeSH Terms] OR ("body"[All Fields] AND 
"weight"[All Fields]) OR "body weight"[All Fields]) OR "ideal body"[All Fields] OR "normal 
body weight"[All Fields]) 
CINAHL Search String (166 Results Identified) 
("periodic fasting" OR "periodic fasts" OR "periodic fast" OR "intermittent fasting" OR 
"intermittent fasts" OR "intermittent fast" OR "intermittent energy restriction" OR "intermittent 
calorie restriction" OR "intermittent caloric restriction" OR "very low calorie diet" OR "very low 
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calorie diets" OR "time restricted feeding") AND (BMI OR "body mass index" OR "weight" OR 
"mass") 
Embase Search String (1287 Results Identified) 
("periodic fasting" OR "periodic fasts" OR "periodic fast" OR "intermittent fasting" OR 
"intermittent fasts" OR "intermittent fast" OR "intermittent energy restriction" OR "intermittent 
calorie restriction" OR "intermittent caloric restriction" OR "very low calorie diet" OR "very low 
calorie diets" OR "time restricted feeding") AND (BMI OR "body mass index" OR "weight" OR 
"mass") 
List of synonyms used in building literature searches 
 Intermittent fasting 
 Alternate day fasting 
 Very-low calorie diet 
 Intermittent energy restriction 
 Intermittent calorie restriction 
 Periodic fasting 
 Periodic calorie restriction 
 5:2 diet 
 Time restricted feeding 
 Time restricted caloric intake 
 Fasting diet 
 Intermittent diet 
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Appendix 2: Extracted Data from Included Studies 
 
Table 1. RCTs reporting weight loss associated with intermittent fasting diets 
 Study Characteristics Outcomes for Weight Loss 
Study Population Interventions and Comparators Sample Size 
Duration of 
Follow Up 
(weeks) 
Weight change (Kg) 
Difference 
between 
groups?* 
Studies with Daily Caloric Restriction as Control Group 
Ash et al.2 
Overweight men with type 
2 diabetes 
I: 48 fasting days, 36 ad libitum 
days.  On fasting days participants 
given 1000 kcal/day w/ liquid 
meal replacement 
14 men 12  -6.4 ± 4.6 (sdb) 
No 
C: 1400-1700 kcal/day 17 men 12 -6.4 ± 4.6 (sd)c 
Carter et 
al.9 
Overweight or obese 
adults with type 2 diabetes 
I: 2 fast days per week, w/ 400-
600 kcal on fast days and ad 
libitum on non-fast days 
31 (17 
women, 14 
men) 
12 -8 
No 
C: Continuous energy restriction 
of  1200-1550 kcal/day 
32 (16 
women, 16 
men) 
12 -8 
Harvie et 
al. Study 
15 
Overweight women 
between ages of 30-45 
years, w/ family history of 
breast cancer 
I: 2 fasting days per week.  On 
fasting days total caloric intake 
<645 kcal/day and total protein 
intake goal was 50g 
53 women 26 -5.7 
 
No 
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C: Standard daily caloric 
restriction (goal caloric intake 
75% of calculated need) 
54 women 26 -4.5 
Harvie et 
al. Study 
26^ 
Overweight women 
between ages of 20-69, w/ 
family history of breast 
cancer 
I: 2 fasting days per week.  On 
fasting days total caloric intake 
was capped at 30% of calculated 
daily caloric need.  Also 40g 
carbohydrate limit on fast days.   
19 women 12 -5.0 
 
No 
C: Standard daily caloric 
restriction (goal caloric intake 
75% of calculated need) 
17 women 12 -4.0 
Hill et al.10  
Obese women 130-160% 
of ideal body weight 
I: Alternating fasting and non-
fasting days: 600 kcal limit on fast 
days, 1800 kcal limit on non-
fasting days.  Half of participants 
required to walk 5 days/week.   
20 women 12 -7.6 
No 
C: Continuous energy restriction: 
1200 kcal/day.  Half of 
participants required to walk 5 
days/week 
20 women 12 -7.6 
 
Varady et 
al Study 
1.3 
Overweight and obese 
adults aged 35-65 with no 
history of cardiovascular 
disease, diabetes, or 
smoking 
I: 42 days of 25% of normal 
caloric requirement alternated w/ 
42 days of ad libitum 
13 (10 
women, 3 
men) 
12 
PERCENT  of BODY 
WEIGHT LOST -5.2 ± 
1.1 (sem) 
No 
C: 75% of normal caloric 
requirement/day 
12 (10 
women, 2 
men) 
12 
PERCENT OF BODY 
WEIGHT LOST -5.0 ± 
1.4 (sem) 
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Studies with Non-interventional or Education-Only Control Groups 
Bhutani et 
al.7,8 
Group 1 
Obese adults aged 25-65.  
Participants with history 
of diabetes, smoking, or 
cardiovascular disease 
were excluded 
I: Fasts every other day.  Fast days 
included 25% of baseline energy 
requirement, consumed between 
12:00pm and 2:00pm 
25 (24 
women, 1 
man) 
12 -3 ± 1 
Yes 
C:  No intervention; participants 
asked to maintain regular food 
habits 
16 (15 
women, 1 
man) 
12 0 ± 0 
Bhutani et 
al.7,8 
Group 2 
Obese adults aged 25-65.  
Participants with history 
of diabetes, smoking, or 
cardiovascular disease 
were excluded 
I: Fasts every other day.  Fast days 
included 25% of baseline energy 
requirement, consumed between 
12:00pm and 2:00pm. Participants 
in this group also required to 
complete moderate-intensity 
endurance exercises 3x weekly 
18 women 12 -6 ± 4 
No 
C: No dietary intervention, but 
participants required to complete 
moderate-intensity endurance 
exercises 3x weekly 
24 (23 
women, 1 
man) 
12 -1 ± 0 
Varady et 
al Study 
2.11 
Normal and overweight 
(but not obese) subjects 
aged 35-65 years.  
Participants w/ history of 
diabetes or cardiovascular 
disease excluded. 
I: Fasts every other day.  Fast days 
included 25% of baseline energy 
requirement, consumed between 
12:00pm and 2:00pm 
15 (10 
women, 5 
men) 
12 
Both groups lost weight.  
Fasting group lost 5.2 ± 
0.9 kg more than non-
fasting group 
Yes 
C:  No intervention; participants 
asked to maintain regular food 
habits 
15 (12 
women, 3 
men) 
12 
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Williams 
et al.4 
Group 1 
Individuals w/ Type 2 
diabetes and ≥20% over 
ideal body weight 
I: 5 fasting days in one week 
followed by 15 weeks with one 
fasting day per week (fast=400-
600 kcal/day) 
18 (9 women, 
9 men) 
20 -9.6 ± 5.7 (sem) 
Yes 
C: Standard behavioral therapy 
18 (11 
women, 7 
men) 
20 -5.4 ± 5.9 (sem) 
Williams 
et al.4 
Group 2 
Individuals w/ Type 2 
diabetes and ≥20% over 
ideal body weight 
I: 5 fasting days in one week 
followed by four 5-day fasting 
periods over the remaining 19 
weeks 
18 (11 
women, 7 
men) 
20 -10.4 ± 5.4 (sem) 
Yes 
C: Standard behavioral therapy 
18 (11 
women, 7 
men) 
20 -5.4 ± 5.9 (sem) 
a Standard error of the mean 
b Standard deviation 
c In this study authors reported pooled weight loss for both groups 
d For these studies, no estimate of precision was included in the value for weight loss 
*Defined as p<0.05 by pairwise t-tests or ANOVA 
^ In this study we excluded the intermittent fasting + ad libitum protein and fat group because the unrestricted consumption of fat and protein 
violated the inclusion criteria of this systematic review 
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Table 2. RCTs reporting intermediate outcomes related to cardiovascular disease and diabetes following implementation of intermittent fasting diet 
 Study Characteristics Cardiovascular Disease and Diabetes Outcomes 
Study Population 
Interventions and 
Comparators 
Sample 
Size 
Duration of 
Follow Up 
(weeks) 
LDL   HDL  Triglycerides  
HgbA1c 
(%) 
FPG  
Difference 
between 
groups?* 
Studies with Daily Caloric Restriction as Control Group 
Ash et al.2 
Overweight 
men with 
type 2 
diabetes 
I: 48 fasting days, 
36 ad libitum days.  
On fasting days 
participants given 
1000 kcal/day w/ 
liquid meal 
replacement 
14 men 12  
-- -- -0.3 -1.2 -- No 
C: 1400-1700 
kcal/day 
17 men 12 
Carter et al.9 
Overweight 
or obese 
adults with 
type 2 
diabetes 
I: 2 fast days per 
week, w/ 400-600 
kcal on fast days 
and ad libitum on 
non-fast days 
31 (17 
women, 
14 men) 
12 - - - 
-0.6+/-
0.8% 
- 
No 
C: Continuous 
energy restriction of  
1200-1550 kcal/day 
32 (16 
women, 
16 men) 
12 - - - 
-.8+/-
1.0% 
- 
Harvie et al.5 
Overweight 
women 
between 
I: 2 fasting days per 
week.  On fasting 
days total caloric 
53 women 26 -0.3 
(mm
0 
(mm
-0.2 
(mmol/L) 
- -0.1 
(mmol/
No  
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ages of 30-
45 years, w/ 
family 
history of 
breast 
cancer 
intake <645 
kcal/day and total 
protein intake goal 
was 50g 
ol/L) ol/L) L)  
C: Standard daily 
caloric restriction 
(goal caloric intake 
75% of calculated 
need) 
54 women 26 
-0.3 
(mm
ol/L) 
-0.1 
(mm
ol/L) 
-0.3 
(mmol/L) 
- 
-0.1 
(mmol/
L) 
Harvie et al.6 
Overweight 
women 
between 
ages of 20-
69, w/ 
family 
history of 
breast 
cancer 
I: 2 fasting days per 
week.  On fasting 
days total caloric 
intake was capped 
at 30% of 
calculated daily 
caloric need.  Also 
40g carbohydrate 
limit on fast days.   
19 women 16 
-0.14 
(mm
ol/L) 
-0.03 
(mm
ol/L) 
- 
+0.3mm
ol/l$ 
-0.1 
No 
C: Standard daily 
caloric restriction 
(goal caloric intake 
75% of calculated 
need) 
17 women 16 
-0.10 
(mm
ol/L) 
+0.0
3 
(mm
ol/L) 
- 
--
0.1mmol
/l 
-0.1 
 
Varady et al 
Study 1.3 
Overweight 
and obese 
adults aged 
35-65 with 
no history of 
I: 42 days of 25% 
of normal caloric 
requirement 
alternated w/ 42 
days of ad libitum 
13 (10 
women, 3 
men) 
12 
-
10+/
-4% 
2+/-
3% 
-15+/-12% -- -- 
Statistically 
significant 
difference 
between 
fasting 
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cardiovascul
ar disease, 
diabetes, or 
smoking 
C: 75% of normal 
caloric 
requirement/day 
12 (10 
women, 2 
men) 
12 
-8+/-
4% 
4+/-
3% 
10+/-12% -- -- 
group and 
caloric 
restriction 
group for 
LDL and 
triglycerides 
Studies with Non-interventional or Education-Only Control Groups 
Bhutani et 
al.7,8 Group 1 
Obese adults 
aged 25-65.  
Participants 
with history 
of diabetes, 
smoking, or 
cardiovascul
ar disease 
were 
excluded 
I: Fasts every other 
day.  Fast days 
included 25% of 
baseline energy 
requirement, 
consumed between 
12:00pm and 
2:00pm 
25 (24 
women, 1 
man) 
12 
-
1mg/
dl 
0 +5mg/dl - -3mg/dl 
No 
C:  No intervention; 
participants asked 
to maintain regular 
food habits 
16 (15 
women, 1 
man) 
12 
+4m
g/dl 
+4m
g/dl 
+5mg/dl - +2mg/dl 
Bhutani et 
al.7,8 Group 2 
Obese adults 
aged 25-65.  
Participants 
with history 
of diabetes, 
smoking, or 
cardiovascul
ar disease 
were 
excluded 
I: Fasts every other 
day.  Fast days 
included 25% of 
baseline energy 
requirement, 
consumed between 
12:00pm and 
2:00pm. 
Participants in this 
group also required 
to complete 
18 women 12 
-
16m
g/dl 
+9m
g/dl 
+10mg/dl  -2mg/dl 
HDL 
increased 
significantly 
in 
fasting+exer
cise group 
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moderate-intensity 
endurance exercises 
3x weekly 
C: No dietary 
intervention, but 
participants 
required to 
complete moderate-
intensity endurance 
exercises 3x weekly 
24 (23 
women, 1 
man) 
12 
+4m
g/dl 
+4m
g/dl 
+5mg/dl - +2mg/dl 
Varady et al 
Study 2.11 
Normal and 
overweight 
(but not 
obese) 
subjects 
aged 35-65 
years.  
Participants 
w/ history of 
diabetes or 
cardiovascul
ar disease 
excluded. 
I: Fasts every other 
day.  Fast days 
included 25% of 
baseline energy 
requirement, 
consumed between 
12:00pm and 
2:00pm 
15 (10 
women, 5 
men) 
12 
-
18+/
-
6mg/
dl 
-2+/-
3mg/
dl 
-22+/-11 - - 
No 
C:  No intervention; 
participants asked 
to maintain regular 
food habits 
15 (12 
women, 3 
men) 
12 
-9+/-
5mg/
dl 
+1+/
-
2mg/
dl 
+10+/-7 - - 
Williams et 
al.4 Group 1 
Individuals 
w/ Type 2 
diabetes and 
≥20% over 
ideal body 
weight 
I: 5 fasting days in 
one week followed 
by 15 weeks with 
one fasting day per 
week (fast=400-600 
kcal/day) 
18 (9 
women, 9 
men) 
20 
-0.15 
(mm
ol/L) 
.03 
(mm
ol/L) 
-1.15 
(mmol/L) 
-0.65+/-
1.35% 
- No 
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C: Standard 
behavioral therapy 
18 (11 
women, 7 
men) 
20  
-0.19 
(mm
ol/L) 
-0.15 
(mm
ol/L) 
-0.66 
(mmol/L) 
-0.71+/-
1.59% 
- 
Williams et 
al.4 Group 2 
Individuals 
w/ Type 2 
diabetes and 
≥20% over 
ideal body 
weight 
I: 5 fasting days in 
one week followed 
by four 5-day 
fasting periods over 
the remaining 15 
weeks 
18 (11 
women, 7 
men) 
20 
-0.19 
(mm
ol/L) 
-0.01 
(mm
ol/L) 
-0.22 
(mmol/L) 
-0.97+/-
1.70% 
- 
No 
C: Standard 
behavioral therapy 
18 (11 
women, 7 
men) 
20 
-0.19 
(mm
ol/L) 
-0.15 
(mm
ol/L) 
-0.66 
(mmol/L) 
-0.23+/-
1.04% 
- 
a Standard error of the mean 
b Standard deviation 
c In this study authors reported pooled weight loss for both groups (which is why the values are the same) 
d For these studies, no estimate of precision was included in the value for weight loss 
*Defined as p<0.05 by pairwise t-tests or ANOVA 
^Subdivide Table By: Studies w/ education/ad libitum-only control groups OR Studies in which control group is some type of caloric restriction 
$ For the study by Harvie et al. HgbA1c was reported at 12 weeks but not at 16 weeks 
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Table 3. Adverse events and outcomes reported in randomized-controlled trials of intermittent fasting 
Study Adverse Events and Outcomes 
Harvie et al. Study 26 ● Decreased Energy 
○ 5% in intermittent fasting group vs 5% in daily energy restriction (control) group 
● Constipation 
○ 8% in intermittent fasting group vs. 3% in controls 
● Headache 
○ 5% in intermittent fasting group vs. 0% in controls 
● Halitosis 
○ 5% in intermittent group vs. 3% in control group 
● Light-headedness 
○ 3% in fasting group vs. 0% in control group 
● Mood instability 
○ 3% in fasting group vs. 5% in control (daily energy restriction) group 
Bhutani et al.8 ● In fasting group hunger decreased and fullness increased over the 12 week study.  Uncontrolled eating 
decreased in the fasting and fasting+exercise groups.  
Carter et al.9 ● Intermittent fasting group and daily caloric restriction group reported decrease in hunger and increase in 
fullness 
Varady et al.11 ● Headaches 
○ 2/15 intervention subjects (13%) 
● Constipation 
○ 1/15 (6.5%) 
■ This resolved by week 3 after participant was encouraged to increase fruit and vegetable 
intake 
 
References 
1. de Groot LCPGM, Van Es AJH, Van Raaij JMA, Vogt JE, Hautvast JGAJ. Adaptation of energy metabolism of overweight women to 
alternating and continuous low energy intake.Am J Clin Nutr. 1989;50: 1314–1323. 
2. Ash S, Reeves MM, Yeo S, Morrison G, Carey D, Capra S. Effect of intensive dietetic interventions on weight and glycaemic control in 
overweight men with Type II diabetes: a randomised trial.Int J Obes. 2003;27: 797–802. 
 52 
 
3. Varady KA, Bhutani S, Klempel MC, Kroeger CM. Comparison of effects of diet versus exercise weight loss regimens on LDL and HDL 
particle size in obese adults.Lipids Health Dis. 2011;10: 119 
4. Williams KV, Mullen ML, Kelley DE, Wing RR. The effect of short periods of caloric restriction on weight loss and glycemic control in type 
2 diabetes.Diabetes Care. 1998;21:2 
5. Harvie MN, Pegington M, Mattson MP, Frystyk J, Dillon B, Evans G et al.The effects of intermittent or continuous energy restriction on 
weight loss and metabolic disease risk markers: a randomized trial in young overweight women.Int J Obes. 2011;35: 714–727 
6. Harvie M, Wright C, Pegington M, McMullan D, Mitchell E, Martin Bet al.The effect of intermittent energy and carbohydrate restriction v. 
daily energy restriction on weight loss and metabolic disease risk markers in overweight women.Br J Nutr. 2013;110: 1534–1547 
7. Bhutani S, Klempel MC, Kroeger CM, Trepanowski JF, Varady KA. Alternate day fasting and endurance exercise combine to reduce body 
weight and favorably alter plasma lipids in obese humans. Obesity (Silver Spring). 2013 Jul;21(7):1370-9. doi: 10.1002/oby.20353. 
8. Bhutani S, Klempel MC, Kroeger CM, Aggour E, Calvo Y, Trepanowski JF, Hoddy KK, Varady KA. Effect of exercising while fasting on 
eating behaviors and food intake. J Int Soc Sports Nutr. 2013 Nov 1;10(1):50. doi: 10.1186/1550-2783-10-50. 
9. Carter S, Clifton PM, Keogh JB. The effects of intermittent compared to continuous energy restriction on glycaemic control in type 2 
diabetes; a pragmatic pilot trial. Diabetes Res Clin Pract. 2016 Dec;122:106-112. doi: 10.1016/j.diabres.2016.10.010. 
10. Hill JO, Schlundt DG, Sbrocco T, Sharp T, Pope-Cordle J, Stetson B, Kaler M, Heim C. Evaluation of an alternating-calorie diet with and 
without exercise in the treatment of obesity. Am J Clin Nutr. 1989 Aug;50(2):248-54. PubMed PMID: 2667313. 
11. Varady KA, Bhutani S, Klempel MC, Kroeger CM, Trepanowski JF, Haus JM, Hoddy KK, Calvo Y. Alternate day fasting for weight loss in 
normal weight and overweight subjects: a randomized controlled trial. Nutr J. 2013 Nov 12;12(1):146. doi: 10.1186/1475-2891-12-146. 
 
 
 
 
 
 
 
 
 
 
 53 
 
Appendix 3: Risk of Bias with Support for Judgement 
 
Table 1. Risk of bias in included studies, with support for judgement.  Assessment performed with Cochrane 
Risk of Bias Tool.11 
Ash et al.1 
Bias 
Author’s Judgement 
of Risk of Bias 
Support for Judgement 
Random Sequence 
Generation (Selection 
Bias) 
Low 
Quote from article: “Following  the  dietary  stabilization  
period  subjects  were randomized, using a random number 
table, into one of three dietary  intervention  groups  for  the  
12-week  intervention period: intermittent  energy  restriction  
(IER),  pre-portioned meals (PPM) and self-selected meals 
(SSM).” 
Allocation 
Concealment 
(Selection Bias) 
Unclear 
Comment: Allocation concealment is not discussed in the 
article 
Blinding of 
Participants and 
Personnel 
(Performance Bias) 
High Comment: Blinding is not discussed in the article 
Blinding of Outcome 
Assessment 
(Detection Bias) 
Unclear 
Comment: Blinding of outcome assessment was not 
performed; however, it is unclear if unblinding of outcome 
assessment could have been a source of detection bias, as the 
measured outcomes were objective physical and serologic 
measurements. 
Incomplete Outcome 
Data (Attrition Bias) 
Low 
Quote from article: “Although loss to follow-up was high, 
subjects studied at 18 months were comparable in  every  
respect  to  the  original study population.” 
 
Comment: Loss to follow up was not significantly different in 
the three experimental groups.   
Selective Reporting 
(Reporting Bias) 
High 
Comment: Change from baseline to 12-weeks of intervention 
were not reported for both groups; outcomes were pooled and 
average weight loss was reported. No protocol or clinical trial 
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registry entry available. 
Other Bias Unclear 
Comment: Study authors declared no conflicts of interest.  
Unclear if the study was at risk of any other bias 
Bhutani et al. (reported in two papers)6,7 
Bias 
Author’s Judgement 
of Risk of Bias 
Support for Judgement 
Random Sequence 
Generation (Selection 
Bias) 
Low 
Quote from article: “Randomization was performed for each 
stratum by selecting an intervention at random from an 
opaque envelope.” 
Allocation 
Concealment 
(Selection Bias) 
Low 
Comment: The allocation concealment was adequate on the 
basis of having a clinical coordinator open a randomly-
selected opaque envelope 
Blinding of 
Participants and 
Personnel 
(Performance Bias) 
High 
Comment: participants and personnel were not blinded to 
intervention 
Blinding of Outcome 
Assessment 
(Detection Bias) 
Unclear 
Comment: Blinding of outcome assessment was not 
performed, however, it is unclear if unblinding of outcome 
assessment could have been a source of detection bias, as the 
measured outcomes were objective physical and serologic 
measurements. 
Incomplete Outcome 
Data (Attrition Bias) 
Low 
Quote from article: “Additional subjects were randomized to 
groups with high dropout rates, such as the ADF and exercise 
group, to ensure that the number of subjects would be the 
same in each group at the end of the trial. Dropouts were 
primarily due to scheduling conflicts.” 
 
Comment: Dropout rates were different across experimental 
groups, however, given that this was primarily a result of 
scheduling and that baseline comparability of groups was 
adequate, this constitutes a threat to external but not internal 
validity.  Furthermore, the measured characteristics of 
dropouts were not significantly different from those of 
successful study completers. 
Selective Reporting Unclear Comment: No protocol or clinical trial registry entry 
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(Reporting Bias) available. 
Other Bias Unclear 
Comment: Study authors declared no conflicts of interest.  
Unclear if the study was at risk of any other bias 
Carter et al.8 
Bias 
Author’s Judgement 
of Risk of Bias 
Support for Judgement 
Random Sequence 
Generation (Selection 
Bias) 
Low 
Quote from article: “Participants were divided into two 
groups, stratified by gender and BMI, and allocated 1:1 to 
treatment groups.” 
Allocation 
Concealment 
(Selection Bias) 
Low 
Comment: Study personnel utilized a computerized random 
number generator for allocation 
Blinding of 
Participants and 
Personnel 
(Performance Bias) 
High 
Quote from article: “...and randomization was not blinded.” 
 
Comment: neither participants nor personnel were blinded at 
any point in the study. 
Blinding of Outcome 
Assessment 
(Detection Bias) 
Unclear 
Comment: Blinding of outcome assessment was not 
performed, however, it is unclear if unblinding of outcome 
assessment could have been a source of detection bias, as the 
measured outcomes were objective physical and serologic 
measurements. 
Incomplete Outcome 
Data (Attrition Bias) 
Low 
Comment: Drop out was low overall and was similar in both 
experimental groups 
Selective Reporting 
(Reporting Bias) 
Low 
Quote: “This study has been registered with the Australia 
New Zealand Clinical Trial Registry (ANZCTR) 
www.anzctr.org.au and given the registration number 
ACTRN12615000383561.” 
  
Comment: No differences found between publication and 
protocol/clinical trial register entry 
Other Bias Unclear 
Comment: Study authors declared no conflicts of interest.  
Unclear if the study was at risk of any other bias 
 56 
 
Harvie et al. Study 14 
Bias 
Author’s Judgement 
of Risk of Bias 
Support for Judgement 
Random Sequence 
Generation (Selection 
Bias) 
Unclear 
Comment: the protocol for random sequence generation is not 
described 
Allocation 
Concealment 
(Selection Bias) 
Unclear 
Comment: the protocol for allocation concealment is not 
described 
Blinding of 
Participants and 
Personnel 
(Performance Bias) 
High Comment: participants and study personnel were not blinded  
Blinding of Outcome 
Assessment 
(Detection Bias) 
Unclear 
Quote from article: “Laboratory personnel were blinded to the 
sample identity.” 
 
Comment: Serologic tests were not subject to detection bias, 
however, it is unclear if unblinding of outcome assessment 
could have been a source of detection bias, as the measured 
outcomes were objective physical measurements. 
Incomplete Outcome 
Data (Attrition Bias) 
Low 
Quote from article: “Eighteen women withdrew from the 
study before 6 months (IER=11, CER=7), representing 21% 
IER and 13% CER subjects ( X2=1.16, P=0.28). The main 
reasons for dropout  were  comparable  between  the  groups:  
stress (IER=3, CER=2), pregnancy (IER=2, CER=1), change 
in employment (IER=2, CER=1), problems adhering to the 
diet (IER=3, CER=3) and personal illness (infected 
pacemaker, IER=1)” 
Selective Reporting 
(Reporting Bias) 
Unclear Comment: No protocol or clinical trial registry entry available 
Other Bias Unclear 
Comment: Tanita Europe provided Tanita TBF-300 
equipment free of charge for use in study, though it is unclear 
if this represented introduction of bias.  It is unclear if the 
study was at risk of any other bias 
Harvie et al. Study 25 
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Bias 
Author’s Judgement 
of Risk of Bias 
Support for Judgement 
Random Sequence 
Generation (Selection 
Bias) 
Unclear 
Comment: the protocol for random sequence generation is not 
discussed 
Allocation 
Concealment 
(Selection Bias) 
Low 
Quote from Article: “Group allocation was established by 
opaque, sealed envelopes that contained the assignment for 
each subject.” 
Blinding of 
Participants and 
Personnel 
(Performance Bias) 
High Comment: participants and study personnel were not blinded  
Blinding of Outcome 
Assessment 
(Detection Bias) 
Low 
Quote from Article: “Personnel performing laboratory  
measurements,  and  inputting  and  analyzing  trial  data were 
blinded to group allocations. Anthropometric measures were 
performed by research dietitians who were not blinded to the 
treatment group” 
 
Comment: Blinding of outcome assessment was not 
performed for anthropometric data, however, it is unclear if 
unblinding of outcome assessment could have been a source 
of detection bias, as the measured outcomes were objective. 
Incomplete Outcome 
Data (Attrition Bias) 
Low 
Quote from article: “We considered it more appropriate to 
report a comparison of the three dietary groups (adjusting for 
multiple testing with Bonferroni correction) with an intention-
to-treat analysis that includes all subjects in a last-
observation-carried-forward  (LOCF)  analysis. 
 
Quote from article: “In total, twenty-seven women withdrew 
from the study (23%): IECR n=4 (11%), IECR+PF n=10 
(26%) and DER n=13 (33%) (X2=5.3, P=0.071).  The reasons 
for the dropout were family/work issues (IECR n=3, 
IECR+PF n=4, DER n=5), unrelated personal illness (IECR 
n=1, IECR+PF n=1, DER n=1), problems adhering to the diet 
(IECR+PF n=2, DER n=3), and loss to follow up (IECR+PF 
n=3, DER n=4).” 
Selective Reporting 
(Reporting Bias) 
Unclear Comment: No protocol or clinical trial registry entry 
available.  Authors used Bonferroni correction to address 
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multiple comparisons. 
Other Bias Unclear 
Comment: Study authors declared no conflicts of interest.  
Unclear if the study was at risk of any other bias 
Hill et al.9 
Bias 
Author’s Judgement 
of Risk of Bias 
Support for Judgement 
Random Sequence 
Generation (Selection 
Bias) 
Unclear 
Comment: the protocol for random sequence generation is not 
discussed 
Allocation 
Concealment 
(Selection Bias) 
Unclear 
Comment: the protocol for allocation concealment is not 
discussed 
Blinding of 
Participants and 
Personnel 
(Performance Bias) 
High 
Comment: neither participants nor study personnel were 
blinded to assignment to intervention or control groups 
Blinding of Outcome 
Assessment 
(Detection Bias) 
Unclear 
Comment: Comment: Blinding of outcome assessment was 
not performed, however, it is unclear if unblinding of outcome 
assessment could have been a source of detection bias, as the 
measured outcomes were objective physical and serologic 
measurements. 
Incomplete Outcome 
Data (Attrition Bias) 
Unclear 
Comment: The authors do not report comparability of dropout 
between groups.  Intention-to-treat analyses were not used. 
Selective Reporting 
(Reporting Bias) 
Unclear 
Comment: No protocol or clinical trial registry entry 
available. 
Other Bias Unclear 
Comment: Study authors declared no conflicts of interest.  
Unclear if the study was at risk of any other bias 
Varady et al. Study 12 
Bias 
Author’s Judgement 
of Risk of Bias 
Support for Judgement 
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Random Sequence 
Generation (Selection 
Bias) 
Unclear 
Comment: the protocol for random sequence generation is not 
discussed 
Allocation 
Concealment 
(Selection Bias) 
Unclear 
Comment: the protocol for allocation concealment is not 
discussed 
Blinding of 
Participants and 
Personnel 
(Performance Bias) 
High 
Comment: neither participants nor study personnel were 
blinded to assignment to intervention or control groups 
Blinding of Outcome 
Assessment 
(Detection Bias) 
Unclear 
Comment: Comment: Blinding of outcome assessment was 
not performed, however, it is unclear if unblinding of outcome 
assessment could have been a source of detection bias, as the 
measured outcomes were objective physical and serologic 
measurements. 
Incomplete Outcome 
Data (Attrition Bias) 
Low 
Quote from article: “Sixty subjects commenced the study, 
with 49 completing the 12-week trial. The remaining subjects 
in each intervention group were as follows: ADF (n = 13), CR 
(n = 12), exercise (n = 12), and control (n = 12).” 
Selective Reporting 
(Reporting Bias) 
Unclear 
Comment: Raw data for many outcomes not reported in tables 
or text but given in graphs or reported as either significant or 
non-significant. No protocol or clinical trial registry entry 
available. 
Other Bias Unclear 
Comment: Study authors declared no conflicts of interest.  
Unclear if the study was at risk of any other bias 
Varady et al. Study 210 
Bias 
Author’s Judgement 
of Risk of Bias 
Support for Judgement 
Random Sequence 
Generation (Selection 
Bias) 
Low 
Quote from article: “Subjects were randomized by KAV by 
way of a stratified random sample. Subjects were first divided 
into strata based on sex (M/F), age (35–50 y/51-65 y), and 
BMI (20–24.9 kg/m2/ 25–29.9 kg/m2), and then subjects from 
each stratum were randomized 1:1 into either the ADF or 
control group” 
Allocation Unclear Comment: the subjects were randomized based on 
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Concealment 
(Selection Bias) 
predetermined strata, however, it is unclear if the 
experimenter who assigned subjects (KAV) was blinded in 
any way to the assignments generated 
Blinding of 
Participants and 
Personnel 
(Performance Bias) 
High 
Comment: neither participants nor study personnel were 
blinded to assignment to intervention or control groups 
Blinding of Outcome 
Assessment 
(Detection Bias) 
Unclear 
Comment: Comment: Blinding of outcome assessment was 
not performed, however, it is unclear if unblinding of outcome 
assessment could have been a source of detection bias, as the 
measured outcomes were objective physical and serologic 
measurements. 
Incomplete Outcome 
Data (Attrition Bias) 
Low 
Comment: Low overall dropout, with rate of dropout and 
characteristics of participants dropping out similar across 
experimental groups.  One participant dropped out of fasting 
group due to difficult adhering to diet.  One participant 
dropped out of the control group due to scheduling conflicts. 
Selective Reporting 
(Reporting Bias) 
Unclear 
Comment: Weight change is only reported as “relative to 
control” but is also shown in Figure 2 to be negative overall.  
Absolute values for weight loss in the two groups are not 
presented.  No protocol or clinical trial registry entry 
available. 
Other Bias Unclear 
Comment: Study authors declared no conflicts of interest.  
Unclear if the study was at risk of any other bias 
Williams et al.3 
Bias 
Author’s Judgement 
of Risk of Bias 
Support for Judgement 
Random Sequence 
Generation (Selection 
Bias) 
Unclear 
Quote from article: “Eligible subjects were blocked by FPG 
after 2 weeks off diabetes medication (<7.8, 7.8-11.1, and 
>11.1 mmol/l) and then randomized, by blocks, to one of 
three treatment conditions. 
 
Comment: Randomization sequence generation is not 
explicitly discussed 
Allocation Unclear Comment: it is not specified if block randomization was 
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Concealment 
(Selection Bias) 
implemented in a manner that minimized allocation 
concealment. 
Blinding of 
Participants and 
Personnel 
(Performance Bias) 
High 
Comment: neither participants nor study personnel were 
blinded to assignment to intervention or control groups 
Blinding of Outcome 
Assessment 
(Detection Bias) 
Unclear 
Comment: Comment: Blinding of outcome assessment was 
not performed, however, it is unclear if unblinding of outcome 
assessment could have been a source of detection bias, as the 
measured outcomes were objective physical and serologic 
measurements. 
Incomplete Outcome 
Data (Attrition Bias) 
Low 
Quote from article: “Dropout rate was  similar  across  
treatment  conditions. Reported reasons for dropping out 
included illness in the family, a change in work schedule, or a 
move to another region of the country that precluded 
attendance at the weekly treatment meetings. Baseline 
characteristics of dropouts were not different  from subjects 
who completed  the study.  Attendance rates at weekly 
treatment meetings did not  differ between groups (P =  
0.62).” 
Selective Reporting 
(Reporting Bias) 
Unclear 
Comment: No protocol or clinical trial registry entry 
available. 
Other Bias Unclear 
Comment: Study authors declared no conflicts of interest.  
Unclear if the study was at risk of any other bias 
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